150
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Relationship between social and cognitive functions in people with schizophrenia

, , , , , , , , , , , , & show all
Pages 2215-2224 | Published online: 30 Aug 2018

Abstract

Purpose

The purpose of the present study was to examine clinical factors related to social function in people with schizophrenia.

Patients and methods

The participants were 55 stabilized outpatients with schizophrenia. Their mean age was 39.36 (SD =10.65) years. Social function was assessed using the Quality of Life Scale (QLS). Cognitive function was evaluated with the Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB). Clinical symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), the Calgary Depression Scale for Schizophrenia, and the Drug-Induced Extrapyramidal Symptoms Scale.

Results

Neither the MCCB cognitive domain score nor composite score was correlated with the QLS scores. However, of the 10 MCCB subtests, the Trail Making Test Part A and the Brief Assessment of Cognition in Schizophrenia-Symbol Coding (BACS-SC) scores were positively correlated with the QLS scores. Among clinical variables, especially the PANSS negative syndrome scale score had a strong negative correlation with the QLS scores. Stepwise regression analyses showed that the PANSS negative syndrome scale score was an independent predictor of the QLS scores, and although the BACS-SC score predicted the QLS common objects and activities subscale score, the association was not so strong compared to the PANSS negative syndrome scale score.

Conclusion

These results indicate that speed of processing evaluated by BACS-SC could predict some aspect of social function but negative symptoms have a much stronger impact on global social function in people with schizophrenia.

Introduction

Although there is heterogeneity with respect to the functional outcome of schizophrenia patients,Citation1 poor functional outcome is often observed.Citation2Citation6 Functional outcome is defined as a wide range of real-world functions including independent living, financial management, employment, and leisure/social activities.Citation7,Citation8 So, social function investigated in this study is considered to be a part of functional outcome.Citation9 Finding contributors to functional outcome is an important issue in schizophrenia research and clinical intervention. Previous studies have shown that several clinical factors such as positiveCitation10Citation15 and negative symptoms,Citation10Citation20 depressive symptoms,Citation11,Citation12,Citation15,Citation16,Citation21,Citation22 and extrapyramidal symptomsCitation11,Citation15,Citation17,Citation19,Citation20 are associated with functional impairments.

Recently, much more attention has been paid to cognitive impairment as it is a core feature of schizophrenia.Citation23,Citation24 Cognitive impairment persists through the illness including premorbid period,Citation25,Citation26 and patients with schizophrenia show about 1–1.5 SD deficits compared to healthy controls in several cognitive domains, particularly memory, attention, executive function, and speed of processing.Citation27Citation29 In schizophrenia research, cognitive function is broadly divided into neurocognition and social cognition.Citation30 Previous studies have indicated that neurocognition such as verbal memory, working memory, executive function, and vigilance are related to functional outcome in people with schizophrenia.Citation31Citation33 And, it is notable that neurocognition may explain 20%–60% of the variance of functional outcome and it may be a stronger predictor than symptomatology.Citation33Citation35 On the other hand, some previous studies have suggested that symptomatology is more influential in functional outcome than neurocognition.Citation15,Citation36Citation38 Among the previous studies, Ertuğrul and Uluğ and Norman et al found no relationship between neurocognition and functional outcome.Citation36,Citation38 More recently, social cognition, referred to as an array of abilities that involve cognitive capability applied to social situations,Citation30 has attracted attention as it is also related to functional outcome.Citation39 The inconsistency among previous studies can be explained by difference of study design, sample population, sample size, cognitive tests, and functional outcome scales; especially, as for assessing cognitive function and functional outcome in people with schizophrenia, researchers have used different neuropsychological tests and functional outcome scales. Therefore, comparisons across studies seem to be difficult.

In such a situation, the National Institute of Mental Health Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Initiative developed a consensus cognitive battery for schizophrenia research, that is the MATRICS Consensus Cognitive Battery (MCCB).Citation40 The MCCB has been recommended as the standard battery for clinical trials of cognition enhancing interventions for schizophrenia by the US Food and Drug Administration. It is a comprehensive cognitive battery that contains not only neurocognitive domains but also social cognitive domains. On the other hand, as for functional outcome, there are no standardized scales at present. However, the six scales selected by the Validation of Everyday Real-World Outcomes (VALERO) study are often used.Citation41 The six scales are as follows: the Quality of Life Scale (QLS), the Specific Level of Functioning, the Social Behavior Schedule, the Social Functioning Scale (SFS), the Independent Living Skills Schedule, and the Life Skills Profile. Among these six scales, considering that the QLS was selected as one of the hybrid scales of social function and everyday living skills in the VALERO study,Citation41 it is thought to be a comprehensive scale for evaluating social function.

Regarding research in this area, interest has shifted from whether cognitive function is related to functional outcome to how cognitive function is related to it. Not all types of cognitive function are equally important when it comes to navigating the real world,Citation23 and as far as we know, it seems unclear which cognitive domain is related to which aspect of functional outcome. Using the Brief Assessment of Cognition in Schizophrenia (BACS) as a test battery of neurocognition, our research group has reported that speed of processing was correlated with the QLS total and all subscales scores and this cognitive domain was an independent predictor of the QLS total score.Citation15 Moreover, since the MCCB was developed, several studies have also reported the relationship between cognitive function measured by it and functional outcome.Citation42Citation52 However, among those studies, few evaluated social function using the QLS.Citation46,Citation49

Therefore, the purpose of the present study was to clarify the relationship between cognitive function measured comprehensively by the MCCB and social function measured by the QLS in people with schizophrenia. It was hypothesized that cognitive function, particularly social cognition, would be related to social function.

Methods

Participants

Fifty-five stabilized outpatients with a Diagnostic and Statistical Manual of Mental Disorders-IV diagnosis of schizophrenia were recruited from the Department of Psychiatry, Tokushima University Hospital. Patients with any organic central nervous system disorders, substance-related disorders, mental retardation, or severe somatic disorders were excluded. After receiving explanations on the content and possible disadvantages of the study as well as confidentiality protection, participants gave written informed consent to participate in this study. All of them had been receiving regular outpatient treatment and had not been hospitalized in the previous 6 months due to exacerbation of psychiatric symptoms.

The study was approved by the Ethics Committee of the University of Tokushima.

Instruments

To assess social function, we used the QLS.Citation53 The QLS is a semi-structured interview that was specially constructed to measure quality of life (QOL) of schizophrenia patients. The reliability and validity of the scale have been confirmed.Citation53,Citation54 The Japanese version had a good inter-rater reliability (intra-class correlation coefficients ranged from 0.75 to 0.98).Citation54 The ratings are based on patients’ self-report and rater’s judgment about the patient’s functioning and life circumstances. This instrument consists of four subscales measured by a total of 21 items. The four subscales are interpersonal relations, instrumental role, intrapsychic foundations, and common objects and activities. Higher scores indicate a better level of social function. In the present study, experienced psychiatrists who had been treating patients and knew the patient’s living circumstances carried out the interviews according to the Evaluation Manual for the QLS.Citation54

To evaluate cognitive function, we used the MCCB which has been developed as a comprehensive measure of cognitive domains significantly impaired in schizophrenia. The MCCB consists of 10 tests that measure seven cognitive domains. They are as follows: speed of processing (Brief Assessment of Cognition in Schizophrenia-Symbol Coding [BACS-SC], Category Fluency Animal Naming [Fluency], and Trail Making Test Part A [TMT-A]), attention/vigilance (Continuous Performance Test-Identical Pairs), working memory (Wechsler Memory Scale III Spatial Span and Letter Number Span), verbal learning (Hopkins Verbal Learning Test-Revised), visual learning (Brief Visuospatial Memory Test-Revised), reasoning and problem solving (Neuropsychological Assessment Battery Maze), and social cognition (Mayer–Salovey–Caruso-Emotional Intelligence Test Managing Emotions [MSCEIT ME]).Citation40 Each raw score for the 10 subtests was standardized to the T-score (mean =50, SD =10). For the cognitive domain consisting of >1 test (speed of processing and working memory), the domain T-score was derived from a composite of the test scores within each domain. For cognitive domains other than the above, T-score represents the domain score. The MCCB composite score gives equal weighting to each of the seven cognitive domains. The MCCB has good test-retest reliability, practicability, and tolerability,Citation40 and it is reported that the Japanese version of the MCCB has good psychometric properties and validity.Citation55 It was reported that the Japanese version had high internal consistency (Cronbach coefficient alpha was 0.72).Citation55 In the present study, data were collected using the Japanese version by clinical psychologists who were well trained for the use of it. As for the data of the MCCB, only T-scores were used for statistical analysis. All participants were evaluated in a room for psychological tests, and it took about 1–2 hours to carry out the neurocognitive evaluation, during which, if needed, participants were able to take a break to avoid effects of fatigue on the examination. All concentrated on the tasks during the evaluation.

Clinical symptoms were evaluated using the Positive and Negative Syndrome Scale (PANSS) and the Calgary Depression Scale for Schizophrenia (CDSS). PANSS is used to assess the severity of various symptoms in people with schizophrenia. It was reported that the scale had a good reliability (the mean inter-rater correlations, Cronbach coefficient alpha, and test-retest reliability indexes for the PANSS scales ranged between 0.83 and 0.87, 0.73 and 0.83, and 0.77 and 0.89, respectively).Citation56Citation58 It includes 30 items and higher scores represent a greater level of symptom severity.Citation56 Experienced treating psychiatrists conducted the semi-structured interviews according to the Evaluation Manual for the PANSS.Citation57 Depressive symptoms were evaluated using the CDSS which was specifically developed to distinguish depressive symptoms from non-depressed symptoms such as positive and negative symptoms or antipsychotic-induced adverse effects in schizophrenia. The scale consists of eight structured questions (depression, hopelessness, self-depreciation, guilty ideas of reference, pathological guilt, morning depression, early wakening, and suicide) followed by one observation item (observed depression) and higher scores represent a greater level of depression.Citation59 The reliability and validity of the Japanese version of it have been confirmed.Citation60 It was reported that the Japanese version of the scale had adequate internal consistency (Cronbach coefficient alpha was 0.82), inter-rater agreement (kappa coefficients ranged from 0.72 to 1.00), and test-retest reliability (test-retest reliability coefficient was 0.86).Citation60 Experienced treating psychiatrists conducted the interviews according to the paper which included the manual for evaluation.Citation61

Drug-induced extrapyramidal adverse effects were evaluated using the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS). The scale consists of eight individual parameters (gait, bradykinesia, sialorrhea, muscle rigidity, tremor, akathisia, dystonia, and dyskinesia) and one global assessment. Higher scores represent a greater level of extrapyramidal adverse effects. The scale has adequate inter-rater reliability (intra-class correlation coefficients ranged from 0.89 to 0.99 for a pair of experienced psychiatrists).Citation62 In the present study, we evaluated the extrapyramidal symptoms score by summing eight individual parameters. Experienced psychiatrists who were treating the participants examined them according to the Rater’s Manual for the DIEPSS.Citation62

Statistical analysis

In order to identify significant associations between the QLS scores and other clinical variables including the MCCB scores, Pearson correlation coefficients were calculated. In addition, we used the false discovery rate correction to adjust for multiple testing. Then, the QLS total score and the subscale scores were chosen as dependent variables. Using the clinical variables that showed significant correlations with each dependent variable, stepwise regression analyses were performed to specify which clinical variables were the best predictor of each dependent variable. Statistical analyses were carried out with IBM SPSS Statistics version 22 for Windows (IBM Corporation, Armonk, NY, USA) and RStudio (RStudio, Inc, Boston, MA, USA; http://www.rstudio.com/).

Results

presents the demographic characteristics and clinical variables of the participants. All participants were Japanese, of whom 28 were men and 27 women. Their mean age was 39.36 years (SD =10.65). All antipsychotic doses were converted to chlorpromazine equivalents using the conversion chart.Citation63

Table 1 Demographic characteristics of participants

shows the results of the correlation analyses between the QLS scores and the MCCB cognitive domain scores. Neither the MCCB cognitive domain score nor composite score was significantly correlated with the QLS scores. shows the results of the correlation analyses between the QLS scores and the MCCB subtest scores. TMT-A was significantly correlated with the QLS total score (r=0.39, p<0.05), interpersonal relations score (r=0.37, p<0.05), intrapsychic foundations score (r=0.39, p<0.05), and common object and activities score (r=0.37, p<0.05). BACS-SC had significant correlations with the QLS total score (r=0.37, p<0.05) and common objects and activities score (r=0.42, p<0.05).

Table 2 Correlation between QLS scores and MCCB cognitive domain scores

Table 3 Correlation between QLS and MCCB subtests scores

The results of the correlation analyses between the QLS scores and the clinical variables other than the MCCB scores are shown in . The PANSS positive syndrome scale score was significantly correlated with the QLS total score (r=−0.45, p<0.01), interpersonal relations score (r=−0.38, p<0.05), intrapsychic foundations score (r=−0.48, p<0.01), and common objects and activities score (r=−0.41, p<0.01). The PANSS negative syndrome scale score had significant correlations with the QLS total score (r=−0.57, p<0.01), interpersonal relations score (r=−0.49, p<0.01), instrumental role score (r=−0.34, p<0.05), intrapsychic foundations score (r=−0.63, p<0.01), and common objects and activities score (r=−0.50, p<0.01). The CDSS score was significantly correlated with the QLS instrumental role score (r=−0.41, p<0.01). The DIEPSS score showed significant correlations with the QLS total score (r=−0.34, p<0.05), interpersonal relations score (r=−0.35, p<0.05), and common objects and activities score (r=−0.36, p<0.05). However, no significant correlation was found between the QLS scores and duration of illness, number of hospitalizations, and dose of antipsychotics.

Table 4 Correlation between QLS scores and other clinical variables

shows the results of the stepwise regression analyses on the QLS scores. The PANSS negative syndrome scale score significantly predicted the QLS total and all subscale scores, and the CDSS score significantly predicted the instrumental role score. Concerning cognitive function, it was revealed that only BACS-SC was a significant predictor of the common objects and activities score but it had much less impact on the subscale than the PANSS negative syndrome scale score.

Table 5 Results of stepwise regression analyses on QLS

Discussion

Results of the correlation analysis in the present study show that TMT-A and BACS-SC to measure speed of processing in the MCCB are related to social function but negative symptoms are more important factors associated with various aspects of social function in people with schizophrenia. Concerning cognitive function, previous studies have shown the importance of speed of processing in functional outcome.Citation15,Citation46,Citation47,Citation64 Lin et al reported that all cognitive domains of the MCCB were significantly correlated with the QLS score and among the cognitive domains, speed of processing was most strongly correlated with the QLS score.Citation46 Lystad et al found that the MCCB speed of processing, along with attention, was most strongly related to and predictive of occupational functioning evaluated by the Work Behavior Inventory.Citation47 Using the BACS, our research group has already reported that speed of processing assessed with BACS-SC was significantly correlated with the QLS total and all subscales scores and it was an independent predictor of the QLS total score and intrapsychic foundations score.Citation15 In the present study, the correlations between BACS-SC and the QLS scores were weaker than those in our previous study. However, as a whole, the results of both the studies are similar. On the other hand, Savilla et al reported that BACS-SC was not correlated with the QLS total score and any of the QLS subscale scores.Citation13 Fiszdon et al found a poor relationship between the digit-symbol subtest of WAIS-III and QLS scores.Citation65 Ojeda et al showed that speed of processing assessed by TMT-A as well as by Stroop Color Test and digit-symbol coding of the WAIS-III was by far the most important cognitive factor that predicted QOL evaluated by the QLS.Citation64 Our finding about TMT-A supports their result. Thus, some studies showed the relationship between speed of processing and functional outcome, but others did not. Although the relationship between the two seemed still unclear, the result of the present study clearly showed a significant relationship between them.

Speed of processing is thought to be a core domain in cognitive dysfunction in people with schizophrenia.Citation27,Citation66,Citation67 Burton et al showed that a three-factor MCCB model representing speed of processing, attention/working memory, and learning fits the data well, and symbol coding that best predicted speed of processing proved to be the best single predictor of overall cognitive performance.Citation66 However, fluency, one of the three tests that measure speed of processing in the MCCB, was not significantly correlated with the QLS scores in the present study. Fluency seems to include speed of speech, whereas TMT-A and BACS-SC seem to include speed of drawing or writing. Therefore, even though these three tests evaluate speed of processing, the cognitive processes they measure may be different. Actually, in the BACS, verbal fluency is regarded as an independent cognitive domain separate from attention and speed of information processing evaluated by BACS-SC. So, we guess that this might have led to no significant correlation between the speed of processing domain of the MCCB and the QLS scores in the present study.

There are some inconsistencies between the present study and previous studies about the relationship between cognitive function and functional outcome. In the present study, neither the neurocognitive domains other than speed of processing evaluated by TMT and BACS-SC, nor social cognition evaluated by MSCEIT ME was correlated significantly with functional outcome. These inconsistencies may be due to the differences of study design, sample population, sample size, and rating scales including cognitive tests. In fact, some studies reported no correlation between neurocognition and functional outcome.Citation36,Citation38 Concerning neurocognition, some researchers showed that verbal memory, working memory, executive function, and vigilance were significantly associated with functional outcome.Citation31Citation33 More recently, a meta-analysis study revealed that a variety of neurocognitive domains such as reasoning and problem solving, processing speed, attention and vigilance, working memory, verbal learning and memory, visual learning and memory, verbal fluency, and overall neurocognition are significantly associated with functional outcome.Citation39 Lystad et al reported that among the MCCB cognitive domains, working memory was the most highly correlated with months of previous employment and social function evaluated by the SFS and was a significant predictor of social function.Citation48 Torgalsbøen et al showed that MCCB attention/vigilance was a significant predictor of social and role functioning assessed by Global Functioning.Citation52 Concerning social cognition, the meta-analysis study described above showed that social cognition, particularly theory of mind was more strongly associated with functional outcome than neurocognition.Citation39 In addition, Schmidt et al reported that social cognition mediated a significant indirect relationship between neurocognition and functional outcome.Citation68 Social cognition consists of multiple domains as well as neurocognition. In schizophrenia, social cognition includes four core domains: “emotion processing” including emotion perception/recognition, understanding emotions, and managing emotions, “social perception” including social context processing and social knowledge, “theory of mind/mental state attribution,” and “attributional style/bias.”Citation69 Nonetheless, many studies investigating the relationship between social cognition and functional outcome evaluated social cognition with emotion perception and/or social perception and/or theory of mind.Citation70Citation76 The MCCB chose MSCEIT ME as a test for social cognition because it is related to functional outcome.Citation40 MSCEIT ME is a test to assess managing emotions. As there have been few studies investigating the relation between managing emotions and functional outcome,Citation46,Citation77Citation80 our result would add a new finding to this area of research.

As for the clinical variables other than cognitive function, the results of the present study indicate that positive and negative symptoms, extrapyramidal symptoms, and depressive symptoms are factors related to poor social function and, in particular, negative symptoms are key factors related to a wide range of social function. The present study shows almost the same findings as our previous studies.Citation14Citation16,Citation20 Other previous studies also have shown that these clinical variables are associated with functional outcome.Citation10Citation13,Citation17Citation19,Citation21,Citation22 Although neurocognition was reported to be a stronger predictor of functional outcome than symptomatology in some previous studies,Citation33Citation35 in the present study, stepwise regression analysis clearly showed that negative symptoms predicted more strongly social function evaluated by the QLS than cognitive function. Several previous studies also have reported the superiority of psychiatric symptoms over cognitive function in relation to functional outcome.Citation36Citation38 In the present study, we evaluated clinical symptoms and functional outcome using the PANSS and QLS, respectively. Conceptual overlap between the items of PANSS and QLS may explain the strong relationship between the two scales to some extent. Particularly, the items of the PANSS negative syndrome scale and the QLS intrapsychic foundations subscale seem to be rather similar. Apart from those findings, it was revealed that the CDSS score predicted the QLS instrumental role subscale score more strongly than the PANSS negative syndrome scale. This finding is consistent with our previous study.Citation15 As the role of a worker, student, or housekeeper/parent evaluated by the QLS instrumental role subscale is thought to be one of the highest social functions, many factors other than cognitive function could affect this domain. This may partly explain the absence of a significant relation between cognitive function and the QLS instrumental role subscale score in the present study. Although the finding that negative symptoms are related to social function has already been reported in previous studies,Citation12Citation20 we have found that the cognitive function of processing speed evaluated by TMT-A and BACS-SC is related to social function and BACS-SC predicts a certain part of social function.

The present study has some limitations. First, because of the cross-sectional study, the causal relationship between clinical variables and social function could not be determined. Second, the sample size was small. Therefore, further research with a larger sample size may be required to confirm the results. Third, as the sample was composed exclusively of stabilized outpatients, the results cannot be generalized to all schizophrenia patients. Fourth, although motivation,Citation81 incentives,Citation82,Citation83 or stigmaCitation84 could affect social function, these factors were not examined in the present study.

Conclusion

As a whole, the results of the present study did not support our hypothesis. They indicate that speed of processing evaluated by BACS-SC in the MCCB could predict some aspect of social function but negative symptoms have a much greater impact on global social function in people with schizophrenia.

Acknowledgments

We are grateful to Ms Mai Doi, Ms Atsuko Watanabe, Ms Ayako Kamitani, and Ms Ayano Arai for their help with cognitive assessment.

Disclosure

The authors report no conflicts of interest in this work.

References

  • LeonhardtBLHulingKHammJARecovery and serious mental illness: a review of current clinical and research paradigms and future directionsExpert Rev Neurother201717111117113028885065
  • BellackASMorrisonRLWixtedJTMueserKTAn analysis of social competence in schizophreniaBr J Psychiatry19901568098182207511
  • GuptaSAndreasenNCArndtSFlaumMHubbardWCZiebellSThe Iowa Longitudinal Study of Recent Onset Psychosis: one-year follow-up of first episode patientsSchizophr Res19972311139050123
  • HegartyJDBaldessariniRJTohenMWaternauxCOepenGOne hundred years of schizophrenia: a meta-analysis of the outcome literatureAm J Psychiatry199415110140914168092334
  • RobinsonDGWoernerMGMcMenimanMMendelowitzABilderRMSymptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorderAm J Psychiatry2004161347347914992973
  • WiersmaDWanderlingJDragomireckaESocial disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centresPsychol Med20003051155116712027051
  • HarveyPDBellackASToward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?Schizophr Bull200935230030619126634
  • SumiyoshiTSumiyoshiCFunctional outcome in patients with schizophrenia: the concept and the measurementAct Nerv Super2015571111
  • BurnsTPatrickDSocial functioning as an outcome measure in schizophrenia studiesActa Psychiatr Scand2007116640341817941964
  • EackSMNewhillCEPsychiatric symptoms and quality of life in schizophrenia: a meta-analysisSchizophr Bull20073351225123717204532
  • HoferARettenbacherMAWidschwendterCGKemmlerGHummerMFleischhackerWWCorrelates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorderEur Arch Psychiatry Clin Neurosci2006256424625516311896
  • RabinowitzJLevineSZGaribaldiGBugarski-KirolaDBerardoCGKapurSNegative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE dataSchizophr Res20121371–314715022316568
  • SavillaKKettlerLGalletlyCRelationships between cognitive deficits, symptoms and quality of life in schizophreniaAust N Z J Psychiatry200842649650418465376
  • TomotakeMKanedaYIgaJSubjective and objective measures of quality of life have different predictors for people with schizophreniaPsychol Rep200699247748717153817
  • UeokaYTomotakeMTanakaTQuality of life and cognitive dysfunction in people with schizophreniaProg Neuropsychopharmacol Biol Psychiatry2011351535920804809
  • AkiHTomotakeMKanedaYSubjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophreniaPsychiatry Res20081581192518160137
  • BrowneSRoeMLaneAQuality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesiaActa Psychiatr Scand19969421181248883573
  • FervahaGFoussiasGAgidORemingtonGImpact of primary negative symptoms on functional outcomes in schizophreniaEur Psychiatry201429744945524630742
  • StrejilevichSAPalatnikAAvilaRLack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychoticsPsychiatry Res20051332–327728015741003
  • YamauchiKAkiHTomotakeMPredictors of subjective and objective quality of life in outpatients with schizophreniaPsychiatry Clin Neurosci200862440441118778437
  • JinHZisookSPalmerBWPattersonTLHeatonRKJesteDVAssociation of depressive symptoms with worse functioning in schizophrenia: a study in older outpatientsJ Clin Psychiatry2001621079780311816869
  • RoccaPBellinoSCalvaresePDepressive and negative symptoms in schizophrenia: different effects on clinical featuresCompr Psychiatry200546430431016175763
  • GreenMFHarveyPDCognition in schizophrenia: past, present, and futureSchizophr Res Cogn201411e1e925254156
  • KrausMSKeefeRSCognition as an outcome measure in schizophreniaBr J Psychiatry Suppl200750s46s5118019044
  • KahnRSKeefeRSSchizophrenia is a cognitive illness: time for a change in focusJAMA Psychiatry201370101107111223925787
  • PalmerBWDawesSEHeatonRKWhat do we know about neuropsychological aspects of schizophrenia?Neuropsychol Rev200919336538419639412
  • DickinsonDRamseyMEGoldJMOverlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophreniaArch Gen Psychiatry200764553254217485605
  • ReichenbergAThe assessment of neuropsychological functioning in schizophreniaDialogues Clin Neurosci201012338339220954432
  • ReichenbergAHarveyPDNeuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findingsPsychol Bull2007133583385817723032
  • HarveyPDPennDSocial cognition: the key factor predicting social outcome in people with schizophrenia?Psychiatry (Edgmont)2010724144
  • GreenMFWhat are the functional consequences of neurocognitive deficits in schizophrenia?Am J Psychiatry199615333213308610818
  • GreenMFKernRSHeatonRKLongitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICSSchizophr Res2004721415115531406
  • GreenMFKernRSBraffDLMintzJNeurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?Schizophr Bull200026111913610755673
  • ChristensenTØThe influence of neurocognitive dysfunctions on work capacity in schizophrenia patients: a systematic review of the literatureInt J Psychiatry Clin Pract20071128910124937554
  • VelliganDIMahurinRKDiamondPLHazletonBCEckertSLMillerALThe functional significance of symptomatology and cognitive function in schizophreniaSchizophr Res199725121319176924
  • ErtuğrulAUluğBThe influence of neurocognitive deficits and symptoms on disability in schizophreniaActa Psychiatr Scand2002105319620111939973
  • MohamedSRosenheckRSwartzMStroupSLiebermanJAKeefeRSRelationship of cognition and psychopathology to functional impairment in schizophreniaAm J Psychiatry2008165897898718450928
  • NormanRMMallaAKCorteseLSymptoms and cognition as predictors of community functioning: a prospective analysisAm J Psychiatry1999156340040510080555
  • FettAKViechtbauerWDominguezMDPennDLvan OsJKrabbendamLThe relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysisNeurosci Biobehav Rev201135357358820620163
  • NuechterleinKHGreenMFKernRSThe MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validityAm J Psychiatry2008165220321318172019
  • LeifkerFRPattersonTLHeatonRKHarveyPDValidating measures of real-world outcome: the results of the VALERO expert survey and RAND panelSchizophr Bull201137233434319525354
  • AugustSMKiwanukaJNMcMahonRPGoldJMThe MATRICS Consensus Cognitive Battery (MCCB): clinical and cognitive correlatesSchizophr Res20121341768222093182
  • DurandDStrassnigMSabbagSFactors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studiesEur Neuropsychopharmacol201525218519125104226
  • GouldFMcGuireLSDurandDSelf-assessment in schizophrenia: accuracy of evaluation of cognition and everyday functioningNeuropsychology201529567568225643212
  • KernRSGoldJMDickinsonDThe MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization studySchizophr Res20111261–312413121159492
  • LinCHHuangCLChangYCClinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophreniaSchizophr Res20131461–323123723478155
  • LystadJUFalkumEHaalandVØNeurocognition and occupational functioning in schizophrenia spectrum disorders: the MATRICS Consensus Cognitive Battery (MCCB) and workplace assessmentsSchizophr Res2016170114314926692347
  • LystadJUFalkumEMohnCThe MATRICS Consensus Cognitive Battery (MCCB): performance and functional correlatesPsychiatry Res201422031094110125242432
  • SabbagSTwamleyEMVellaLHeatonRKPattersonTLHarveyPDAssessing everyday functioning in schizophrenia: not all informants seem equally informativeSchizophr Res20111311–325025521620682
  • ShamsiSLauALenczTCognitive and symptomatic predictors of functional disability in schizophreniaSchizophr Res20111261–325726420828991
  • SumiyoshiCHarveyPDTakakiMFactors predicting work outcome in Japanese patients with schizophrenia: role of multiple functioning levelsSchizophr Res Cogn20152310511229379760
  • TorgalsbøenAKMohnCCzajkowskiNRundBRRelationship between neurocognition and functional recovery in first-episode schizophrenia: results from the second year of the Oslo multi-follow-up studyPsychiatry Res20152272–318519125890693
  • HeinrichsDWHanlonTECarpenterWTJrThe Quality of Life Scale: an instrument for rating the schizophrenic deficit syndromeSchizophr Bull19841033883986474101
  • HeinrichsDWHanlonTCarpenterWTJrThe Quality of Life ScaleTokyoSeiwa Publishers2001 Japanese
  • KanedaYOhmoriTOkahisaYMeasurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery: validation of the Japanese versionPsychiatry Clin Neurosci201367318218823581870
  • KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull19871322612763616518
  • KaySROplerLAFiszbeinAPositive and Negative Syndrome Scale (PANSS) Rating ManualTokyoSeiwa Publishers1991 Japanese
  • KaySROplerLALindenmayerJPReliability and validity of the positive and negative syndrome scale for schizophrenicsPsychiatry Res1988231991103363019
  • AddingtonDAddingtonJMaticka-TyndaleEAssessing depression in schizophrenia: the Calgary Depression ScaleBr J Psychiatry1993163Suppl 223944
  • KanedaYFujiiAOhmoriTPsychometric properties of the Japanese version of the Calgary Depression Scale for SchizophrenicsJ Nerv Ment Dis2000188423723910790002
  • KanedaYOhmoriTAddingtonDThe Calgary Depression Scale for SchizophreniaNo To Shinkei2000522163166 Japanese10723756
  • InadaTEvaluation and Diagnosis of Drug-Induced Extrapyramidal Symptoms: Commentary on the DIEPSS and Guide to its UsageTokyoSeiwa Publishers1996 Japanese
  • InadaTInagakiAPsychotropic dose equivalence in JapanPsychiatry Clin Neurosci201569844044725601291
  • OjedaNSánchezPPeñaJAn explanatory model of quality of life in schizophrenia: the role of processing speed and negative symptomsActas Esp Psiquiatr2012401101822344491
  • FiszdonJMChoiJGouletJBellMDTemporal relationship between change in cognition and change in functioning in schizophreniaSchizophr Res20081051–310511318657398
  • BurtonCZVellaLHarveyPDPattersonTLHeatonRKTwamleyEWFactor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophreniaSchizophr Res20131461–324424823507359
  • Rodríguez-SánchezJMCrespo-FacorroBGonzález-BlanchCPerez-IglesiasRVázquez-BarqueroJLCognitive dysfunction in first-episode psychosis: the processing speed hypothesisBr J Psychiatry2007Suppl 51s107s110
  • SchmidtSJMuellerDRRoderVSocial cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modelingSchizophr Bull201137Suppl 2S41S5421860046
  • PinkhamAEPennDLGreenMFBuckBHealeyKHarveyPDThe social cognition psychometric evaluation study: results of the expert survey and RAND panelSchizophr Bull201440481382323728248
  • BrekkeJKayDDLeeKSGreenMFBiosocial pathways to functional outcome in schizophreniaSchizophr Res2005802–321322516137859
  • BoraEEryavuzAKayahanBSunguGVeznedarogluBSocial functioning, theory of mind and neurocognition in outpatients with schizophrenia; mental state decoding may be a better predictor of social functioning than mental state reasoningPsychiatry Res20061452–39510317074402
  • MeyerMBKurtzMMElementary neurocognitive function, facial affect recognition and social-skills in schizophreniaSchizophr Res20091101–317317919328653
  • PijnenborgGHWithaarFKEvansJJvan den BoschRJTimmermanMEBrouwerWHThe predictive value of measures of social cognition for community functioning in schizophrenia: implications for neuropsychological assessmentJ Int Neuropsychol Soc200915223924719203437
  • PinkhamAEPennDLNeurocognitive and social cognitive predictors of interpersonal skill in schizophreniaPsychiatry Res20061432–316717816859754
  • SergiMJRassovskyYNuechterleinKHGreenMFSocial perception as mediator of the influence of early visual processing on functional status in schizophreniaAm J Psychiatry2006163344845416513866
  • VaskinnASundetKFriisSEmotion perception and learning potential: mediators between neurocognition and social problem-solving in schizophrenia?J Int Neuropsychol Soc200814227928818282325
  • EackSMGreenoCGPogue-GeileMFNewhillCEHogartyGEKeshavanMSAssessing social-cognitive deficits in schizophrenia with the Mayer–Salovey–Caruso Emotional Intelligence TestSchizophr Bull201036237038018648021
  • EackSMPogue-GeileMFGreenwaldDPHogartySSKeshavanMSMechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophreniaPsychol Med20114161253126120860867
  • FiszdonJMFanningJRJohannesenJKBellMDSocial cognitive deficits in schizophrenia and their relationship to clinical and functional statusPsychiatry Res20132051–2252923017655
  • KeeKSHoranWPSaloveyPEmotional intelligence in schizophreniaSchizophr Res20091071616818805674
  • Najas-GarciaAGómez-BenitoJHuedo-MedinaTBThe relationship of motivation and neurocognition with functionality in schizophrenia: a meta-analytic reviewCommunity Ment Health J Epub2018331
  • ReddyLFLlerenaKKernRSPredictors of employment in schizophrenia: the importance of intrinsic and extrinsic motivationSchizophr Res20161762–346246627567733
  • SilversteinSMBridging the gap between extrinsic and intrinsic motivation in the cognitive remediation of schizophreniaSchizophr Bull201036594995620064900
  • CaveltiMRüschNVauthRIs living with psychosis demoralizing? Insight, self-stigma, and clinical outcome among people with schizophrenia across 1 yearJ Nerv Ment Dis2014202752152924933416